Treatment or prevention of respiratory viral infections with...

Details Treatment or prevention of respiratory viral infections with... Treatment or prevention of respiratory viral infections with...

A - Human Necessities

61

K

A61K 38/00 (2006.01)

Patent

CA 2522891

An alpha thymosin peptide is administered to a patient having, or at risk of a respiratory viral infection, coronavirus infection and/or SARS.

L'invention concerne un peptide de thymosine alpha administré à un patient présentant une infection virale respiratoire ou en courant le risque d'une infection virale respiratoire, d'une infection par coronavirus et/ou d'une infection SARS.

Affiliated with

Also associated with

Rating

Treatment or prevention of respiratory viral infections with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment or prevention of respiratory viral infections with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment or prevention of respiratory viral infections with... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1675214